this article also applies to WMDBOULDER, Colo., March 23, 2021 /CNW/ - (TSX: CWEB) (OTCQX: CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the CBD industry pioneer, market leader and a Certified B Corporation, today reports the clinical results of a Validcare study conducted over the past seven months. The study's results reaffirm the safety of Charlotte's Web™ hemp derived CBD extracts. Charlotte's Web and 11 other companies supported the study to provide sound scientific data on liver toxicity to federal and state regulators including U.S Congress and the U.S. Food and Drug Administration ("FDA"). Researchers reported of the 839 participants, zero liver toxicity or disease was detected.